(Q41739292)

8 October 2017

0 references

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials (English)

1 reference

8 October 2017

Roach M 3RD

1

1 reference

8 October 2017

Lu J

2

1 reference

8 October 2017

Pilepich MV

3

1 reference

8 October 2017

Asbell SO

4

1 reference

8 October 2017

Mohiuddin M

5

1 reference

8 October 2017

Terry R

6

1 reference

8 October 2017

Grignon D

7

1 reference

8 October 2017

Lawton C

8

1 reference

8 October 2017

Shipley W

9

1 reference

8 October 2017

Cox J

10

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

International Journal of Radiation Oncology Biology Physics

8 October 2017

published in

1 reference

8 October 2017

volume

47

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

617-627

1 reference

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Radical prostatectomy for high grade disease: a reevaluation 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900577-0

7 January 2021

10.1016/S0360-3016(00)00577-0

Identifiers

DOI

1 reference

8 October 2017

1 reference